Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To determine the effect of intravenous recombinant tissue plasminogen activator (rt-PA) on vascular and neurologic outcomes, we enrolled 31 patients with acute carotid artery-territory ischemic stroke within 6 hours from symptom onset in a randomized, double-blind, placebo-controlled study. We gave either rt-PA (duteplase at the dose of 20 or 30 mega-international units [MIU]) or placebo intravenously for 60 minutes in patients randomly assigned to the three groups. A comparison between the baseline and postinfusion angiograms showed that complete or partial reperfusion occurred in 50% (5/10) of patients treated with 30 MIU rt-PA, 44% (4/9) of those treated with 20 MIU rt-PA, and 17% (2/12) in the control group. In patients with middle cerebral artery occlusions, reperfusion occurred in 71% (5/7) of the 30-MIU group, in 67% (4/6) of the 20-MIU group, and in 13% (1/8) of the control group. Patients treated with 30 MIU rt-PA showed a significantly early and better clinical improvement, as measured by the neurologic scale, than did those treated with placebo. Parenchymal hemorrhage occurred in one patient in each group, and frequency of clinically insignificant hemorrhagic infarction was comparable among the treatment groups. No major systemic complications occurred in any group. These results support the efficacy of intravenous infusion of rt-PA soon after the onset of stroke in producing rapid thrombolysis and neurologic recovery; it may be of particular value in patients with thromboembolic occlusion in the middle cerebral artery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Cited by
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Emberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60584-5 · Cited by 2,737
Treatment Strategies for Acute Ischemic Stroke Caused by Carotid Artery Occlusion
Li, W., Yin, Q., Xu, G., & Liu, X. (2016) · Interventional Neurology · doi:10.1159/000445304 · Cited by 2,319
The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis
Rha, J.-H., & Saver, J. L. (2007) · Stroke · doi:10.1161/01.str.0000258112.14918.24 · Cited by 1,452
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
'Malignant' Middle Cerebral Artery Territory Infarction: Clinical Course and Prognostic Signs
Hacke, W. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550040037012 · Cited by 1,352
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.
Lyden, P., Brott, T., Tilley, B., Welch, K. M., Mascha, E. J., Levine, S., Haley, E. C., Grotta, J., & Marler, J. (1994) · Stroke · doi:10.1161/01.str.25.11.2220 · Cited by 1,285
del Zoppo, G. J., Higashida, R. T., Furlan, A. J., Pessin, M. S., Rowley, H. A., & Gent, M. (1998) · Stroke · doi:10.1161/01.str.29.1.4 · Cited by 1,239
Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L., & Cohen, G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60738-7 · Cited by 1,010
del Zoppo, G. J., Saver, J. L., Jauch, E. C., & Adams, H. P. (2009) · Stroke · doi:10.1161/strokeaha.109.192535 · Cited by 829
Fiorelli, M., Bastianello, S., von Kummer, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., Ringleb, A. P., Lorenzano, S., Manelfe, C., & Bozzao, L. (1999) · Stroke · doi:10.1161/01.str.30.11.2280 · Cited by 777
Adams, H. P., Brott, T. G., Furlan, A. J., Gomez, C. R., Grotta, J., Helgason, C. M., Kwiatkowski, T., Lyden, P. D., Marler, J. R., Torner, J., et al. (1996) · Circulation · doi:10.1161/01.cir.94.5.1167 · Cited by 730
Sacks, D., Baxter, B., Campbell, B. C. V., Carpenter, J. S., Cognard, C., Dippel, D., Eesa, M., Fischer, U., Hausegger, K., Hirsch, J. A., et al. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2017.11.026 · Cited by 686
From the American Association of Neurological Surgeons (AANS), A. S. O. N. (., Sacks, D., Baxter, B., Campbell, B. C. V., Carpenter, J. S., Cognard, C., Dippel, D., Eesa, M., Fischer, U., Hausegger, K., et al. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5638 · Cited by 599
Yamaguchi, T., Mori, E., Minematsu, K., Nakagawara, J., Hashi, K., Saito, I., & Shinohara, Y. (2006) · Stroke · doi:10.1161/01.str.0000227191.01792.e3 · Cited by 515
Self-citationAdams, H. P., Brott, T. G., Crowell, R. M., Furlan, A. J., Gomez, C. R., Grotta, J., Helgason, C. M., Marler, J. R., Woolson, R. F., & Zivin, J. A. (1994) · Stroke · doi:10.1161/01.str.25.9.1901 · Cited by 488
Ogawa, A., Mori, E., Minematsu, K., Taki, W., Takahashi, A., Nemoto, S., Miyamoto, S., Sasaki, M., & Inoue, T. (2007) · Stroke · doi:10.1161/strokeaha.107.488551 · Cited by 481
Self-citationTreatment of Acute Ischemic Stroke
Brott, T., & Bogousslavsky, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431007 · Cited by 398
Mori, E., del Zoppo, G. J., Chambers, J. D., Copeland, B. R., & Arfors, K. E. (1992) · Stroke · doi:10.1161/01.str.23.5.712 · Cited by 378
Self-citationStreptokinase for Acute Ischemic Stroke With Relationship to Time of Administration
Donnan, G. A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120039031 · Cited by 360
Advances in the Vascular Pathophysiology of Ischemic Stroke
del Zoppo, G. J., & Hallenbeck, J. M. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00218-8 · Cited by 322
Albers, G. W., Lansberg, M. G., Kemp, S., Tsai, J. P., Lavori, P., Christensen, S., Mlynash, M., Kim, S., Hamilton, S., Yeatts, S. D., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493017701147 · Cited by 313
Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/Reperfusion
Hamann, G. F., Okada, Y., & del Zoppo, G. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00036 · Cited by 290
Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke
Wardlaw, J., Warlow, C., & Counsell, C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03022-5 · Cited by 287
The neurovascular unit in the setting of stroke
Del Zoppo, G. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02199.x · Cited by 285
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub2 · Cited by 267
Linfante, I., Llinas, R. H., Selim, M., Chaves, C., Kumar, S., Parker, R. A., Caplan, L. R., & Schlaug, G. (2002) · Stroke · doi:10.1161/01.str.0000021001.18101.a5 · Cited by 262
Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke
DEL ZOPPO, G. J., VON KUMMER, R., & HAMANN, G. F. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.1 · Cited by 261
Methodology of the Interventional Management of Stroke III Trial
Khatri, P., Hill, M. D., Palesch, Y. Y., Spilker, J., Jauch, E. C., Carrozzella, J. A., Demchuk, A. M., Martin, R., Mauldin, P., Dillon, C., et al. (2008) · International Journal of Stroke · doi:10.1111/j.1747-4949.2008.00151.x · Cited by 261
Kassem-Moussa, H., & Graffagnino, C. (2002) · Archives of Neurology · doi:10.1001/archneur.59.12.1870 · Cited by 135
Metadata
- Authors
- Mori, E., Yoneda, Y., Tabuchi, M., Yoshida, T., Ohkawa, S., Ohsumi, Y., Kitano, K., Tsutsumi, A., & Yamadori, A.
- Venue
- Neurology
- Published
- 1992-05
- Volume
- 42
- Issue
- 5
- Pages
- 976-976
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2157281786
- Cited by
- 472
- References
- 1
- FWCI
- 24.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.